 Co-Diagnostics NASDAQ:CODX Inc, a molecular diagnostics company, has completed the principal design work on a PCR test for the monkeypox virus, the company announced. Outbreaks of the virus have been reported in roughly 20 countries primarily in Europe where it is not endemic, with more than 200 confirmed or suspected infections, according to reporting from Reuters and others. 